Maruyama, S., Ikeda, Y., Kaname, S., Kato, N., Matsumoto, M., Ishikawa, Y., . . . Okada, H. (2024). Eculizumab for adult patients with atypical haemolytic-uraemic syndrome. Journal of Nephrology, 37(8), 2181-2190. https://doi.org/10.1007/s40620-024-01921-y
Chicago-referens (17:e uppl.)Maruyama, Shoichi, et al. "Eculizumab for Adult Patients with Atypical Haemolytic-uraemic Syndrome." Journal of Nephrology 37, no. 8 (2024): 2181-2190. https://doi.org/10.1007/s40620-024-01921-y.
MLA-referens (9:e uppl.)Maruyama, Shoichi, et al. "Eculizumab for Adult Patients with Atypical Haemolytic-uraemic Syndrome." Journal of Nephrology, vol. 37, no. 8, 2024, pp. 2181-2190, https://doi.org/10.1007/s40620-024-01921-y.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
